<p>|P_START
<s>|S_START this|DT could|MD be|VB the|DT end|NN of|IN the|DT road|NN for|IN big|JJ pharmas|NNS failed|VBD business|NN model|NN </s>|S_END
<s>|S_START in|IN recent|JJ years|NNS the|DT worlds|NNS innovative|VBP drug|NN giants|NNS have|VBP seen|VBN research|NN productivity|NN plummet|NN even|RB as|IN the|DT costs|NNS of|IN research|NN have|VBP soared|VBN </s>|S_END
<s>|S_START hare|NN prices|NNS have|VBP taken|VBN a|DT beating|NN as|IN the|DT industry|NN has|VBZ failed|VBN to|TO come|VB up|RP with|IN enough|JJ promising|NN blockbuster|NN drugs|NNS to|TO compensate|VB for|IN the|DT revenue|NN lost|VBD when|WRB old|JJ moneyspinners|NNS lose|VBP their|PRP$ patent|NN protection|NN </s>|S_END
<s>|S_START even|RB the|DT recent|JJ round|NN of|IN mergers|NNS and|CC acquisitions|NNS instigated|VBD by|IN large|JJ firms|NNS such|JJ as|IN pfizer|NN and|CC merck|NN followed|VBD by|IN the|DT requisite|JJ costcutting|NN and|CC sackings|NNS has|VBZ failed|VBN to|TO fix|VB what|WP ails|NNS the|DT industry|NN </s>|S_END
</p>|P_END

<p>|P_START
<s>|S_START the|DT heart|NN of|IN the|DT problem|NN is|VBZ the|DT looming|VBG patent|NN “cliff”|NN see|NN chart|NN </s>|S_END
<s>|S_START evaluatepharma|NN a|DT consultancy|NN estimates|VBZ that|IN 13|CD of|IN global|JJ pharmaceutical|JJ sales|NNS are|VBP at|IN risk|NN from|IN generic|JJ competition|NN in|IN the|DT coming|VBG two|CD year|NN </s>|S_END
<s>|S_START this|DT matters|NNS because|IN the|DT price|NN of|IN a|DT given|VBN drug|NN falls|NNS by|IN more|RBR than|IN 85|CD within|IN a|DT year|NN of|IN patent|NN expiry|NN in|IN competitive|JJ markets|NNS like|IN the|DT united|VBN state|NN </s>|S_END
<s>|S_START over|IN the|DT next|JJ year|NN company|NN bosses|VBZ had|VBD better|RBR come|VBN up|RP with|IN improved|VBN business|NN models|NNS or|CC else|RB they|PRP will|MD drive|VB their|PRP$ firms|NNS right|RB off|IN that|DT precipice|NN </s>|S_END
</p>|P_END

<p>|P_START
<s>|S_START and|CC yet|RB the|DT industrys|NNS salvation|NN could|MD very|RB well|RB lie|VB in|IN the|DT embrace|NN of|IN that|DT very|RB same|JJ nemesis—generic|JJ drug|NN </s>|S_END
<s>|S_START the|DT coming|VBG year|NN will|MD bring|VB dramatic|JJ moves|NNS by|IN big|JJ pharma|NN to|TO learn|VB from|IN copy|NN and|CC even|RB get|VB into|IN bed|VBN with|IN the|DT rivals|NNS it|PRP once|RB decried|VBD as|IN copycats|NNS and|CC scofflaw|NN </s>|S_END
<s>|S_START the|DT explanation|NN for|IN this|DT startling|JJ turn|NN of|IN events|NNS is|VBZ twofold|VBN in|IN the|DT rich|JJ world|NN generic|JJ drugs|NNS are|VBP advancing|VBG as|IN a|DT result|NN of|IN government|NN action|NN whereas|NNS in|IN the|DT developing|VBG world|NN it|PRP is|VBZ the|DT booming|VBG middle|NN class|NN that|WDT is|VBZ propelling|VBG them|PRP forward|RB </s>|S_END
</p>|P_END

<p>|P_START
<s>|S_START first|JJ the|DT developed|VBN world|NN </s>|S_END
<s>|S_START in|IN 2010|CD rich|JJ countries|NNS will|MD boost|VB the|DT fortunes|NNS of|IN generic|JJ drugs|NNS in|IN two|CD way|NN </s>|S_END
<s>|S_START in|IN many|JJ such|JJ countries|NNS from|IN japan|JJ to|TO germany|VB governments|NNS struggling|VBG to|TO control|NN health|NN costs|NNS will|MD introduce|VB policies|NNS that|WDT favour|PRP$ the|DT use|NN of|IN cheap|NN generic|JJ drug|NN </s>|S_END
<s>|S_START the|DT american|NN precedent|NN suggests|VBZ this|DT will|MD be|VB a|DT powerful|JJ trend|NN </s>|S_END
<s>|S_START from|IN 1999|CD to|TO 2008|CD the|DT use|NN of|IN generic|JJ drugs|NNS saved|VBD america|NN some|DT $|$ 734|CD billion|CD </s>|S_END
<s>|S_START and|CC the|DT boom|NN is|VBZ set|VBN to|TO continue|VB with|IN the|DT american|JJ generics|NNS sector|NN forecast|NN to|TO grow|VB by|IN over|IN 9|CD a|DT year|NN to|TO 2012|CD </s>|S_END
</p>|P_END

<p>|P_START
<s>|S_START taking|VBG the|DT medicine|NN </s>|S_END
</p>|P_END

<p>|P_START
<s>|S_START but|CC carrots|NNS will|MD soon|RB be|VB accompanied|VBN by|IN stick|NN </s>|S_END
<s>|S_START regulators|NNS at|IN americas|NNS federal|JJ trade|NN commission|NN and|CC at|IN the|DT european|JJ commission|NN have|VBP already|RB expressed|VBN their|PRP$ displeasure|NN at|IN perceived|VBN antitrust|JJ violations|NNS involving|VBG big|JJ pharmas|NNS efforts|NNS to|TO thwart|VB competition|NN from|IN generics|NNS through|IN for|IN example|NN “pay|NN for|IN delay”|NN deals|NNS that|WDT bribe|NN rivals|NNS to|TO put|VB back|RP the|DT launch|NN of|IN generic|JJ pill|NN </s>|S_END
<s>|S_START the|DT year|NN ahead|RB could|MD well|RB see|VB tough|JJ talk|NN turn|NN to|TO regulatory|JJ action|NN </s>|S_END
<s>|S_START this|DT trend|NN too|RB should|MD change|VB attitudes|NNS at|IN big|JJ firms|NNS so|IN that|IN generics|NNS are|VBP not|RB seen|VBN merely|RB as|IN pests|NNS to|TO be|VB tolerated|VBN or|CC paid|VBN off|RP but|CC rather|RB as|IN inspiration|NN for|IN a|DT radically|RB different|JJ business|NN model|NN </s>|S_END
</p>|P_END

<p>|P_START
<s>|S_START that|DT is|VBZ especially|RB true|JJ when|WRB it|PRP comes|VBZ to|TO the|DT developing|VBG world|NN which|WDT is|VBZ where|WRB the|DT action|NN is|VBZ these|DT day|NN </s>|S_END
<s>|S_START in|IN 2010|CD much|JJ of|IN the|DT revenue|NN growth|NN for|IN the|DT drugs|NNS industry|NN overall|NN will|MD come|VB from|IN the|DT leading|VBG economies|NNS of|IN the|DT poor|JJ world|NN </s>|S_END
<s>|S_START ims|NNS health|VBP another|DT consultancy|NN calculates|VBZ that|IN the|DT seven|CD biggest|JJS emerging|VBG pharma|NN markets|NNS made|VBN up|RP more|JJR than|IN half|PDT of|IN the|DT global|JJ industrys|NNS total|VBP sales|NNS growth|NN in|IN 2009|CD </s>|S_END
<s>|S_START by|IN 2012|CD nine|CD of|IN the|DT top|JJ 20|CD markets|NNS will|MD be|VB emerging|VBG economie|NN </s>|S_END
</p>|P_END

<p>|P_START
<s>|S_START the|DT trick|NN to|TO winning|NN over|IN the|DT rising|VBG middle|NN classes|NNS in|IN such|JJ markets|NNS is|VBZ not|RB to|TO peddle|VB overpriced|VBN patented|VBN drugs|NNS on|IN the|DT western|NN model|NN cursing|VBG the|DT local|JJ generics|NNS firms|NNS as|IN ripoff|NN artist|NN </s>|S_END
<s>|S_START big|JJ pharma|NN has|VBZ tried|VBN that|IN route|NN for|IN years|NNS with|IN little|JJ succe|NN </s>|S_END
<s>|S_START rather|RB the|DT key|JJ is|VBZ to|TO pitch|VB branded|VBN generic|JJ drug|NN </s>|S_END
<s>|S_START these|DT are|VBP offpatent|JJ pills|NNS and|CC potions|NNS that|WDT can|MD be|VB sold|VBN more|JJR cheaply|RB than|IN the|DT onpatent|NN variety|NN but|CC which|WDT still|RB command|VBP an|DT attractive|JJ price|NN premium|NN in|IN poor|JJ countries|NNS due|JJ to|TO the|DT proliferation|NN in|IN local|JJ markets|NNS of|IN fakes|NNS and|CC drugs|NNS of|IN dubious|JJ quality|NN </s>|S_END
</p>|P_END

<p>|P_START
<s>|S_START in|IN 2010|CD the|DT big|JJ western|NN drugs|NNS firms|NNS will|MD enter|VB the|DT branded|VBN generics|NNS markets|NNS in|IN full|JJ force|NN by|IN joining|NN up|IN with|IN local|JJ generics|NNS firms|NNS to|TO get|VB cheap|NN access|NN to|TO this|DT booming|NN niche|NN </s>|S_END
<s>|S_START a|DT few|JJ pioneers|NNS have|VBP already|RB headed|VBN down|RP this|DT path|NN </s>|S_END
</p>|P_END

<p>|P_START
<s>|S_START ome|NN like|IN americas|NNS pfizer|VBP have|VBP experimented|VBN with|IN licensing|NN deals|NNS and|CC alliances|NNS with|IN asian|JJ generics|NNS firm|NN </s>|S_END
<s>|S_START others|NNS have|VBP gone|VBN a|DT bit|NN further|RB as|IN britains|NNS glaxosmithkline|VBP did|VBD with|IN its|PRP$ recent|JJ acquisition|NN of|IN a|DT share|NN in|IN aspen|NN an|DT african|JJ firm|NN specialising|VBG in|IN branded|JJ generic|JJ </s>|S_END
<s>|S_START yet|RB others|NNS go|VBP the|DT full|JJ monty|NN as|IN japans|NNS daiichi|VBP sankyo|NN did|VBD by|IN gobbling|NN up|IN indias|NNS ranbaxy|VBP laboratorie|NN </s>|S_END
<s>|S_START watch|NN for|IN a|DT dramatic|JJ acceleration|NN of|IN this|DT trend|NN in|IN the|DT coming|VBG year—which|JJ could|MD even|RB lead|VB to|TO the|DT end|NN of|IN the|DT independent|JJ generics|NNS industry|NN in|IN india|NN </s>|S_END
</p>|P_END

<p>|P_START
<s>|S_START taken|VBN together|RB these|DT trends|NNS point|VBP to|TO 2010|CD being|VBG a|DT turningpoint|NN for|IN the|DT global|JJ generics|NNS busine|VBP </s>|S_END
<s>|S_START big|JJ pharma|NN is|VBZ in|IN big|JJ trouble|NN but|CC it|PRP may|MD yet|RB find|VB comfort|NN in|IN the|DT arms|NNS of|IN that|DT erstwhile|JJ foe|NN </s>|S_END
</p>|P_END

<p>|P_START
<s>|S_START vijay|NN vaitheeswaran|VBD healthcare|NN correspondent|NN the|DT economist|NN </s>|S_END
</p>|P_END

